Antibody Development Segment has the Largest Share of Service in the Middle East and Africa Custom Antibody Market during 2021-2028
According to a new market research study on “Middle East and Africa Custom Antibody Market to 2028 - COVID-19 Impact and Regional Analysis and Forecast by Service, Type, Source, Research Area, and End-user,” is expected to reach US$ 25.0 million by 2028 from US$ 14.0 million in 2021. The market is estimated to grow at a CAGR of 8.6% from 2021 to 2028. The report provides trends prevailing in the Middle East and Africa custom antibody market along with the drivers and restraints pertaining to the market growth. The growth of this market is estimated to grow owing to key driving factors such as the high demand in research, market consolidations strategies adopted by biotechnology companies, and production and development services offered by custom antibody providers are the key factors driving the market growth. However, the market is expected experiencing slow growth during the forecast period owing to the high cost of production.
The pandemic has affected the research and development activities in these countries. Apart from this, a considerable population already faces a growing burden of non-communicable diseases, making them more vulnerable to the virus. Moreover, economic uncertainties and ongoing conflicts are worsening the condition in the region. For instance, countries such as Syria, Libya, and Yemen are suffering violent conflict and have been unable to implement any public health measures. In addition, Iran was in a deep economic recession due to the US sanctions. These factors are expected to impact the growth of the market in the region negatively. In addition, the primary source of economic stabilization in Middle East countries is oil production and export. However, the current pandemic is creating turbulence in the economics of the Middle East region. An immediate drop in domestic and external demand for goods and products, primarily crude oil, and halted production due to labor deficiency are significant impacts observed in the region. Additionally, tightened financial condition is also decreasing the overall economic activities in the area. This uncertainty with average delays often associated with regulatory approvals in low- and middle-income countries is hindering the market's growth.
The market for custom antibody market is segmented into service, type, source, research area, and End-user. Based on service, the custom antibody market is segmented into antibody development, antibody production and purification, antibody fragmentation and labelling. In 2020, the antibody development segment held the largest share of the market, also the same segment is estimated to grow at a significant CAGR due to growing focus of researchers on high-quality custom antibodies for reproducibility during the forecast period.
Thermo Fisher Scientific Inc. Bio-Rad Laboratories Inc. Merck KGAA, Abcam, Genscript, and Agilent Technologies, Inc. are among the leading companies in the Middle East and Africa custom antibody market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in May 2020, Thermo Fisher Scientific has entered into collaboration with WuXi Diagnostics and the Mayo Clinic to develop ELISA test for detection of IgM and IgG antibodies to the novel coronavirus.
The pandemic has affected the research and development activities in these countries. Apart from this, a considerable population already faces a growing burden of non-communicable diseases, making them more vulnerable to the virus. Moreover, economic uncertainties and ongoing conflicts are worsening the condition in the region. For instance, countries such as Syria, Libya, and Yemen are suffering violent conflict and have been unable to implement any public health measures. In addition, Iran was in a deep economic recession due to the US sanctions. These factors are expected to impact the growth of the market in the region negatively. In addition, the primary source of economic stabilization in Middle East countries is oil production and export. However, the current pandemic is creating turbulence in the economics of the Middle East region. An immediate drop in domestic and external demand for goods and products, primarily crude oil, and halted production due to labor deficiency are significant impacts observed in the region. Additionally, tightened financial condition is also decreasing the overall economic activities in the area. This uncertainty with average delays often associated with regulatory approvals in low- and middle-income countries is hindering the market's growth.
The market for custom antibody market is segmented into service, type, source, research area, and End-user. Based on service, the custom antibody market is segmented into antibody development, antibody production and purification, antibody fragmentation and labelling. In 2020, the antibody development segment held the largest share of the market, also the same segment is estimated to grow at a significant CAGR due to growing focus of researchers on high-quality custom antibodies for reproducibility during the forecast period.
Thermo Fisher Scientific Inc. Bio-Rad Laboratories Inc. Merck KGAA, Abcam, Genscript, and Agilent Technologies, Inc. are among the leading companies in the Middle East and Africa custom antibody market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in May 2020, Thermo Fisher Scientific has entered into collaboration with WuXi Diagnostics and the Mayo Clinic to develop ELISA test for detection of IgM and IgG antibodies to the novel coronavirus.
The report segments the Middle East and Africa Custom Antibody market as follows:
By Service
- Antibody Development
- Antibody Production and Purification
- Antibody Fragmentation and Labelling
By Type
- Monoclonal Antibodies
- Polyclonal Antibodies
- Other Custom Antibodies
By Source
- Mice
- Rabbits
- Others
By Research Area
- Oncology
- Immunology
- Stem Cells
- Infectious Diseases
- Neurobiology
- Cardiovascular Diseases
- Others
By End-user
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutes
- Contract Research Organizations
By Country
- Middle East and Africa
- UAE
- Saudi Arabia
- South Africa
- Rest of Middle East and Africa
Reasons to buy:
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Middle East and Africa custom antibody market
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the Middle East and Africa custom antibody market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth Middle East and Africa market trends and outlook coupled with the factors driving the custom antibody market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution
Frequently Asked Questions about the Middle Eastern and African Custom Antibody Market
What is the estimated value of the Middle Eastern and African Custom Antibody Market?
What is the growth rate of the Middle Eastern and African Custom Antibody Market?
What is the forecasted size of the Middle Eastern and African Custom Antibody Market?
Who are the key companies in the Middle Eastern and African Custom Antibody Market?
| Report Attribute | Details |
|---|---|
| No. of Pages | 167 |
| Published | July 2021 |
| Forecast Period | 2021 - 2028 |
| Estimated Market Value ( USD | $ 14 Million |
| Forecasted Market Value ( USD | $ 25 Million |
| Compound Annual Growth Rate | 8.6% |
| Regions Covered | Africa, Middle East |
Table of Contents
1. Introduction
3. Research Methodology
4. Middle East and Africa Custom Antibody Market - Market Landscape
5. Middle East and Africa Custom Antibody Market - Key Market Dynamics
6. Custom Antibody Market - Middle East and Africa Analysis
7. Middle East and Africa Custom Antibody Market Analysis and Forecasts To 2028 - By Service
8. Middle East and Africa Custom Antibody Market Analysis and Forecasts To 2028 - By Type
9. Middle East and Africa Custom Antibody Market Analysis and Forecasts To 2028 - By Source
10. Middle East and Africa Custom Antibody Market Analysis and Forecasts to 2028 - By Research Area
11. Middle East and Africa Custom Antibody Market Analysis and Forecasts to 2028 - By End User
12. Custom Antibody Market Revenue and Forecasts to 2028 - Geographical Analysis
13. Impact Of COVID-19 Pandemic on Middle East and Africa Custom Antibody Market
14. Industry Landscape
15. COMPANY PROFILES
16. Appendix
List of Tables
List of Figures
Companies Mentioned
A selection of companies mentioned in this report includes:
- Thermo Fisher Scientific Inc.
- Bio-Rad Laboratories Inc.
- Merck KGAA
- Abcam
- Genscript
- Agilent Technologies, Inc.
